Diego Albani Selected Research

Oxidopamine (6 Hydroxydopamine)

12/2017	Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine.
10/2017	Recombinant human Tat-Hsp70-2: A tool for neuroprotection.
1/2015	The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity.
11/2004	Protective effect of TAT-delivered alpha-synuclein: relevance of the C-terminal domain and involvement of HSP70.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Diego Albani Research Topics

Disease

39	Alzheimer Disease (Alzheimer's Disease) 10/2023 - 05/2005
13	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 12/2008
8	Cognitive Dysfunction 01/2019 - 04/2010
8	Parkinson Disease (Parkinson's Disease) 12/2017 - 11/2004
7	Major Depressive Disorder (Major Depressive Disorders) 01/2023 - 07/2013
6	Neuroblastoma 11/2021 - 05/2005
5	Dementia (Dementias) 01/2019 - 04/2010
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2015
4	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 01/2016 - 01/2008
3	Schizophrenia (Dementia Praecox) 01/2022 - 01/2017
3	Disease Progression 01/2019 - 01/2013
3	Neoplasms (Cancer) 09/2014 - 01/2010
2	Epilepsy (Aura) 05/2022 - 09/2010
2	Mood Disorders (Mood Disorder) 01/2022 - 12/2013
2	Genetic Risk Score 01/2022 - 01/2021
2	Atrophy 01/2019 - 01/2019
2	Neuroinflammatory Diseases 01/2018 - 04/2010
2	Frontotemporal Dementia (Semantic Dementia) 04/2016 - 01/2016
2	Retinoblastoma (Glioblastoma, Retinal) 03/2010 - 03/2002
1	Blister (Bulla) 03/2023
1	Seizures (Absence Seizure) 05/2022
1	Inflammation (Inflammations) 10/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Amyloidosis 01/2021
1	Nervous System Diseases (Neurological Disorders) 09/2019
1	Treatment-Resistant Depressive Disorder 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2019
1	Prodromal Symptoms 01/2019
1	Synucleinopathies 01/2018
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 05/2017
1	AIDS-Related Complex (ARC) 01/2017
1	Syndrome (Syndromes) 01/2017
1	Drug-Related Side Effects and Adverse Reactions 01/2015

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2020 - 11/2004
10	Biomarkers (Surrogate Marker)IBA 04/2021 - 01/2013
9	Antidepressive Agents (Antidepressants)IBA 01/2023 - 07/2013
7	Peptides (Polypeptides)IBA 04/2021 - 09/2009
7	Apolipoproteins E (ApoE)IBA 01/2021 - 01/2008
7	Amyloid (Amyloid Fibrils)IBA 01/2020 - 03/2011
6	HydrogelsIBA 11/2021 - 12/2009
5	Amyloid beta-PeptidesIBA 04/2021 - 07/2007
5	SirtuinsIBA 01/2014 - 01/2010
4	alpha-SynucleinIBA 01/2018 - 11/2004
4	Oxidopamine (6 Hydroxydopamine)IBA 12/2017 - 11/2004
4	Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA 01/2011 - 01/2008
3	PolymersIBA 01/2020 - 12/2009
3	Presenilin-1IBA 01/2019 - 11/2007
3	Antipsychotic Agents (Antipsychotics)IBA 01/2019 - 01/2017
3	Flavin-Adenine Dinucleotide (FAD)IBA 10/2018 - 11/2007
3	ProgranulinsIBA 04/2016 - 01/2009
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2016 - 01/2012
3	Sirtuin 2IBA 01/2016 - 07/2013
3	Sirtuin 1IBA 01/2016 - 09/2009
3	CytokinesIBA 02/2013 - 01/2010
3	ApolipoproteinsIBA 04/2012 - 01/2008
3	ResveratrolIBA 09/2010 - 09/2009
2	Donepezil (Aricept)FDA LinkGeneric 10/2023 - 01/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2023 - 01/2008
2	NeurotoxinsIBA 01/2020 - 09/2019
2	SynucleinsIBA 01/2015 - 04/2013
2	ElementsIBA 07/2013 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2012 - 01/2010
2	Interleukin-1alpha (Interleukin 1 alpha)IBA 04/2012 - 01/2009
1	Lamin Type A (Lamin A)IBA 03/2023
1	Serotonin and Noradrenaline Reuptake InhibitorsIBA 01/2023
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2023
1	Chondroitin Sulfates (Chondroitin Sulfate)IBA 11/2021
1	rho-Associated KinasesIBA 10/2021
1	fasudil (AT 877)IBA 10/2021
1	Glycogen Synthase Kinase 3 betaIBA 10/2021
1	GraphiteIBA 04/2021
1	1,5-diaminonaphthaleneIBA 04/2021
1	FurinIBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	CollagenIBA 01/2020
1	Ethylene Glycol (Monoethylene Glycol)IBA 01/2020
1	ferulic acid (sodium ferulate)IBA 10/2019
1	Memantine (Namenda)FDA Link 10/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 10/2019
1	salsolinolIBA 09/2019
1	AmmoniaIBA 09/2019
1	methylglyoxal bis(3-aminopropylamidinohydrazone)IBA 01/2019
1	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2018
1	Escitalopram FDA Link 12/2017
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 12/2017
1	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 10/2017
1	Sirtuin 3IBA 05/2017
1	NucleotidesIBA 05/2017
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017
1	tau Proteins (tau Protein)IBA 01/2016
1	Cholinergic ReceptorsIBA 01/2016
1	MicroRNAs (MicroRNA)IBA 01/2016
1	RNA (Ribonucleic Acid)IBA 01/2016
1	sortilinIBA 01/2015

Therapy/Procedure

7	Therapeutics 10/2023 - 01/2013
2	Injections 11/2013 - 01/2013
1	Diet Therapy (Therapy, Diet) 05/2022
1	Electrodes (Electrode) 04/2021
1	Precision Medicine 01/2019